corporate_fare

Vestfold Hospital Trust

Address
P. O. Box 2168

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
6
research centres
public
1
country
person_search
6
investigators

Specializations

Obesity in adolescents

Vestfold Hospital Trust’s research activity is centred on obesity care for treatment-seeking adolescents, with interest in body weight reduction, body mass index change, and clinical management of severe excess weight in young people.

  • Adolescent obesity
  • Weight management
  • Body mass index outcomes

The sponsor’s clinical focus includes structured care for adolescents with obesity who are seeking treatment in a hospital-based setting.

Endocrine and metabolic health

The research portfolio reflects an interest in metabolic disease linked to excess adiposity, with attention to hormonal regulation, energy balance, and metabolic risk in paediatric and adolescent populations.

  • Metabolic health
  • Hormonal regulation
  • Energy balance

Clinical work in this area connects endocrine care with long-term management of weight-related disease.

Nutrition and low-energy dietary care

Vestfold Hospital Trust also shows interest in nutrition-based interventions, including low-energy diet support and dietary treatment strategies used alongside behavioural care for obesity.

  • Low-energy diet
  • Dietary intervention
  • Nutrition support

This area highlights clinical involvement in nutritional management for adolescents with excess weight.

Behavioural therapy and eHealth-supported care

The sponsor is engaged in research combining behavioural therapy with electronic health tools, reflecting interest in blended face-to-face and digital support for adolescents with obesity.

  • Behavioural therapy
  • eHealth
  • Digital health support

Its clinical research includes care models that integrate psychological support and technology-enabled treatment for weight-related conditions.

Pharmacological treatment in obesity care

Vestfold Hospital Trust has an active interest in anti-obesity pharmacotherapy, particularly GLP-1 receptor agonist treatment within adolescent weight management pathways.

  • Anti-obesity medication
  • GLP-1 receptor agonist
  • Adjunct treatment

This area links medication-based care with broader clinical management of adolescent obesity in a specialist hospital setting.

Sponsored Trials

Trial Name Country Status
Evaluation of Semaglutide and Low Energy Diet in Adolescents with Obesity: A Randomized Controlled TrialNorway NorwayRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)

This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 6 sites collaborated multiple times

This sponsor has worked with 6 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Nutritional and Metabolic Diseases1 trial
    211 other sponsors

Partnered Research Centres

6 centres
location_city
assignment2
Finnmarkssykehuset HF
Address
Sykehusveien 35, 9601 Hammerfest
Learn morearrow_forward
location_city
assignment231
Helse Bergen HF
Address
Haukelandsveien 22, 5021 Bergen
Learn morearrow_forward
location_city
assignment35
Nordlandssykehuset HF
Address
Parkveien 95, 8005 Bodø
Learn morearrow_forward
location_city
assignment472
Oslo Universitetssykehus HF
Address
Montebello, Ullernchausséen 70, 0379 Oslo
Learn morearrow_forward
location_city
assignment173
St. Olavs Hospital HF
Address
Prinsesse Kristinas Gate 3, 7030 Trondheim
Learn morearrow_forward
location_city
assignment12
Vestfold Hospital Trust
Address
P. O. Box 2168, 3103 Tønsberg
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Vestfold Hospital Trust.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.